Edesa Biotech Inc. Common Shares (EDSA)
EDSA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.85
-3.23% on the day
Market cap
$38.4M
Nano cap
Revenue
No annual revenue filed since the period ending 2021-09-30
Net income
No annual revenue filed since the period ending 2021-09-30
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | EDSA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001540159 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials
No annual revenue filed since the period ending 2021-09-30.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-08-20 |
| Latest annual report FORM 10-K | 10-K | 2025-12-12 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-08-20 |
| Latest proxy | DEFA14A | 2026-04-03 |
Source: SEC EDGAR submissions feed, 746 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| VERU | Veru Inc. | $2.19 | -8.94% | $37.3M |
| SCYX | SCYNEXIS Inc. | $3.99 | -0.99% | $39.7M |
| NSRX | Nasus Pharma Ltd. | $3.16 | -4.82% | $37.0M |
| LITS | Lite Strategy Inc. | $1.21 | -0.82% | $36.8M |
| IXHL | Incannex Healthcare Inc. | $2.91 | +0.34% | $36.5M |
| FLNA | Filana Therapeutics Inc. | $0.7434 | -3.39% | $35.9M |
| GRCE | Grace Therapeutics Inc. | $1.99 | -1.49% | $41.9M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier